Device manufacturer, as written on reports
Angiomed & Medizintechnik Kg: medical device reports filed with FDA
5,082 reports name it as the manufacturer of the device involved, 2001–2026.
- 5,082
- reports naming it as manufacturer
- 0% of all MAUDE reports
- 327
- reports, 12 months to August 2026
- 457 in the 12 months before
- 73%
- classified as malfunction
- 62.3% across all reports
- 1.2%
- classified as death, as reported
- 0.9% across all reports
5,082 medical device reports received by FDA give Angiomed & Medizintechnik Kg as the manufacturer of the device involved, 0% of the MAUDE database, from January 2001 to August 2026. Manufacturer names are as written on the report; subsidiaries and spelling variants may appear as separate names.
327 reports arrived in the 12 months to August 2026, down 28% from 457 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (73%), injury (25.8%) and death (1.2%). Manufacturers are required to report events they learn of, so a large manufacturer with many products in use files many reports. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands named most often
| Brand | Device type | Reports | Latest 12 months | Classified as death |
|---|---|---|---|---|
| Fluency Plus Vascular Stent Graft | System, endovascular graft, arteriovenous (av) dialysis access circuit stenosis treatment | 728 | 64 | 0.4% |
| Venovo Venous Stent | Stent, iliac vein | 549 | 74 | 0.5% |
| E-Luminexx Vascular Stent | Stent, iliac | 457 | 32 | 5.1% |
| Lifestent Solo Vascular Stent System | Stent, superficial femoral artery | 390 | 0 | 0% |
| LifeStent 5F Vascular Stent | Stent, superficial femoral artery | 332 | 54 | 0.6% |
| Covera Vascular Covered Stent | System, endovascular graft, arteriovenous (av) dialysis access circuit stenosis treatment | 328 | 42 | 0.3% |
| LifeStent Vascular Stent | Stent, superficial femoral artery | 318 | 7 | 2.9% |
| Lifestent XL Vascular Stent | Stent, superficial femoral artery | 265 | 20 | 0.7% |
| Fluency Plus Endovascular Stent Graft | System, endovascular graft, arteriovenous (av) dialysis access circuit stenosis treatment | 195 | 35 | 0.6% |
| Lifestent Vascular Stent System | Stent, superficial femoral artery | 195 | 0 | 0.5% |
| Fluency Plus Tracheobronchial Stent Graft | Prosthesis, tracheal, expandable | 88 | 0 | 0% |
| Flair Endovascular Stent Graft | System, endovascular graft, aortic aneurysm treatment | 5 | 0 | 0.3% |
| Lifestream Balloon Expandable Vascular Covered Stent | Iliac covered stent, arterial | 1 | 0 | 4.4% |
Brands with a page on this site, ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Device types
| Product code | Device type | Reports | Share |
|---|---|---|---|
| NIP | Stent, superficial femoral artery | 1,996 | 39.3% |
| PFV | System, endovascular graft, arteriovenous (av) dialysis access circuit stenosis treatment | 1,492 | 29.4% |
| QAN | Stent, iliac vein | 607 | 11.9% |
| NIO | Stent, iliac | 562 | 11.1% |
| FGE | Stents, drains and dilators for the biliary ducts | 255 | 5% |
| JCT | Prosthesis, tracheal, expandable | 115 | 2.3% |
| GAA | Needle, aspiration and injection, disposable | 21 | 0.4% |
| KNW | Instrument, biopsy | 8 | 0.2% |
| FAD | Stent, ureteral | 4 | 0.1% |
| MIH | System, endovascular graft, aortic aneurysm treatment | 3 | 0.1% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type
Grey bar: all 26,136,888 MAUDE reports. Event type is the filer's classification and is not verified by FDA.
Questions about Angiomed & Medizintechnik Kg reports
How many FDA device reports name Angiomed & Medizintechnik Kg as manufacturer?
5,082 reports through August 2026, 327 of them in the latest 12 months.
Which of its brands appear most often?
Fluency Plus Vascular Stent Graft (728), Venovo Venous Stent (549), E-Luminexx Vascular Stent (457), Lifestent Solo Vascular Stent System (390) and LifeStent 5F Vascular Stent (332).
Which device types does it report on?
stent, superficial femoral artery (39.3%), system, endovascular graft, arteriovenous (av) dialysis access circuit stenosis treatment (29.4%), stent, iliac vein (11.9%) and stent, iliac (11.1%).
Does a high count say something about the manufacturer?
Not by itself. Manufacturers must file a report for every event they become aware of, so report volume follows the number of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. Manufacturer names are pooled after company suffixes (Inc., LLC, GmbH and similar) are dropped; names that read as a person rather than an organisation are never published. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.